- Wildflower Brands is poised to take its cannabis brand into Europe, beginning with Poland, thanks to its recently announced arrangement with major pharmaceutical distributor Two Towers
- Analysts anticipate a coming cannabidiol (CBD) boom in Europe, where related products are only just beginning to gain attention
- This and other acquisitions are seen as the first steps in Wildflower’s carefully planned strategy for international growth
An agreement between wellness brand builder Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) and wholesale medicinal product distributor Two Towers indicates that doors are opening to a potential array of important new markets for Wildflower as the company builds on its partner’s established capabilities. Two Towers, a major wholesale prescription medical and over-the-counter wellness distribution company in Poland, is an extension of Omega Rex, a group of 14 pharmacies around the central capital region of Warsaw, with critical expertise in dealing with the regulatory process. Two Towers, with operational relationships throughout Europe as well as other parts of the world, distributes products from an extensive list of global leaders in pharmaceutical and consumer packaged goods.
Two Towers specializes in powdered food for children and other baby nutrition products, including medications, nutritional supplements and fast moving consumer goods (“FMCG”). The initial Two Towers agreement will allow Wildflower to begin marketing its CBD+ line of products in Poland, with a view of launching into the entire European Union as Wildflower Wellness cannabidiol products establish themselves on a solid footing.
“The European market is fragmented with no CBD market leaders,” Wildflower CEO William MacLean stated in a news release announcing the agreement (http://ibn.fm/RXZHB). “Our agreement with Two Towers vastly reduces barriers to moving our products between member states. This will position Wildflower as a market leader as the EU members begin opening their markets to CBD.”
Market analysts at the Brightfield Group recently reported a market forecast that envisions a boom in the European cannabidiol market during the next four years. The market is expected to grow by more than 400 percent from an estimated $318 million in sales last year as cannabidiol products begin to take hold there (http://ibn.fm/wqFy6).
“CBD is just starting to take hold in Europe, with both product availability and consumer awareness still quite limited,” Brightfield Managing Director Bethany Gomez stated in a release. “This is a great opportunity for developed brands to enter and expand through Europe with far less competition than we’re seeing in the U.S. With the Novel Foods Act, it is a challenging legal environment to operate in, but impending regulatory changes are likely to smooth the way for significant mid-term growth.”
For more information, visit the company’s website at www.WildflowerBrands.co
NOTE TO INVESTORS: The latest news and updates relating to WLDFF are available in the company’s newsroom at http://ibn.fm/WLDFF
